Thyrocare Technologies Ltd

Thyrocare Tech. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Thyrocare Technologies Ltd

₹ 650 -0.12%
16 May 2:25 p.m.
thyrocare.com BSE: 539871 NSE: THYROCARE
About

Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India.

Key Points

World’s leading Diagnostic center Incorporated in the year 1996, as a single economical thyroid testing center in Mumbai and now has become the world's leading Diagnostic chain which offers a wide range of medical diagnostic tests and management of diseases and disorders. [1]

Website BSE NSE
  • Market Cap ₹ 3,442 Cr.
  • Current Price ₹ 650
  • High / Low ₹ 723 / 448
  • Stock P/E 48.4
  • Book Value ₹ 97.0
  • Dividend Yield 2.83 %
  • ROCE 18.6 %
  • ROE 13.8 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 118%
  • Debtor days have improved from 50.3 to 28.0 days.

Cons

  • The company has delivered a poor sales growth of 7.19% over past five years.
  • Promoters have pledged 100% of their holding.
  • Working capital days have increased from 64.3 days to 106 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
139 159 169 110 123 119 125 117 125 124 136 123 141
88 89 82 74 86 85 96 91 102 90 100 92 108
Operating Profit 51 71 87 36 37 34 30 26 23 33 37 31 34
OPM % 36% 44% 52% 33% 30% 28% 24% 22% 18% 27% 27% 25% 24%
2 3 2 1 2 1 1 1 2 0 2 2 3
Interest 0 1 1 1 1 1 1 1 1 1 1 1 1
Depreciation 6 6 7 7 9 8 8 9 9 9 9 11 10
Profit before tax 47 67 82 29 29 27 22 18 15 24 28 21 25
Tax % 25% 28% 26% 22% 31% 24% 35% 28% 33% 31% 28% 28% 23%
35 48 61 23 20 20 14 13 10 17 20 15 19
EPS in Rs 6.68 9.15 11.45 4.27 3.85 3.80 2.70 2.39 1.88 3.16 3.83 2.81 3.63
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
134 150 180 235 298 332 370 401 474 562 486 524
71 81 109 140 182 193 222 233 304 330 371 390
Operating Profit 64 69 71 95 115 139 148 168 171 232 115 134
OPM % 47% 46% 40% 40% 39% 42% 40% 42% 36% 41% 24% 26%
18 7 13 6 -16 21 14 -35 12 7 5 7
Interest 0 0 0 1 0 0 0 1 1 3 5 4
Depreciation 3 6 11 11 12 12 14 20 21 28 34 39
Profit before tax 78 69 73 89 87 148 147 112 161 207 81 98
Tax % 27% 33% 33% 34% 46% 35% 35% 29% 26% 27% 30% 28%
57 46 49 59 47 96 95 79 120 152 57 71
EPS in Rs 52.04 42.28 9.75 10.94 8.69 17.87 18.04 15.01 22.65 28.74 10.76 13.43
Dividend Payout % 0% 0% 157% 91% 115% 56% 111% 33% 110% 52% 167% 134%
Compounded Sales Growth
10 Years: 13%
5 Years: 7%
3 Years: 3%
TTM: 8%
Compounded Profit Growth
10 Years: 4%
5 Years: -5%
3 Years: -15%
TTM: 29%
Stock Price CAGR
10 Years: %
5 Years: 8%
3 Years: -14%
1 Year: 40%
Return on Equity
10 Years: 20%
5 Years: 21%
3 Years: 18%
Last Year: 14%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 11 11 51 54 54 54 53 53 53 53 53 53
Reserves 149 195 229 322 364 400 403 325 393 468 468 461
25 25 0 0 0 0 0 9 10 21 21 39
11 14 14 39 26 31 32 55 73 55 70 68
Total Liabilities 197 246 293 414 444 485 488 442 528 597 612 620
75 87 83 93 89 103 108 112 119 149 157 159
CWIP 10 6 6 1 2 0 1 4 8 2 1 1
Investments 77 119 162 266 299 315 289 239 274 259 274 291
34 33 42 55 54 68 89 88 127 186 180 169
Total Assets 197 246 293 414 444 485 488 442 528 597 612 620

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
46 46 36 67 89 112 97 136 111 106 120 155
-88 -52 -21 -19 -40 -48 -3 27 -53 -12 -32 -80
1 0 -23 -45 -48 -65 -96 -163 -58 -87 -88 -84
Net Cash Flow -42 -6 -7 3 1 -1 -3 1 0 6 1 -9

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 9 12 9 11 7 10 11 14 34 60 63 28
Inventory Days 54 54 47 54 64 66 54 60 50 54 63 106
Days Payable 2 13 5 8 4 23 19 62 48 30 52 83
Cash Conversion Cycle 61 53 51 57 68 53 46 12 37 84 74 51
Working Capital Days 19 22 52 15 28 11 4 -9 9 49 38 106
ROCE % 50% 33% 27% 27% 29% 33% 31% 36% 37% 41% 15%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
66.14% 71.22% 71.18% 71.18% 71.18% 71.14% 71.14% 71.14% 71.14% 71.14% 71.11% 71.11%
13.19% 12.10% 12.02% 12.68% 12.82% 10.42% 10.13% 9.99% 3.44% 3.46% 3.35% 2.90%
6.38% 6.59% 6.71% 6.88% 7.15% 9.14% 8.68% 8.45% 13.46% 13.33% 13.89% 14.88%
14.29% 10.09% 10.09% 9.26% 8.85% 9.29% 10.04% 10.40% 11.95% 12.08% 11.64% 11.11%
No. of Shareholders 53,14062,93665,76966,31566,43171,41275,82274,38676,29272,00068,84464,823

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls